Order expected to affect specific medications covered under Medicare that are administered in a health care setting.

Persistent hyperglycemia linked to increased odds of worsening left ventricular hypertrophy over seven years. (HealthDay News) — Adolescent hyperglycemia and worsening insulin resistance (IR ...

Personal attitudes, practice patterns, and lack of knowledge are reported barriers. (HealthDay News) — While treating sexual problems is considered an important health care practice, general ...

More favorable diagnostic yield seen with annual versus biennial screening. (HealthDay News) — Annual multicancer early detection (MCED) screening with a single blood test provides more overall ...

mRNA-1083 induced higher immune responses than recommended standard-care influenza and COVID-19 vaccines. (HealthDay News) — mRNA-1083 vaccine is noninferior and induces higher immune responses ...

Pain control was achieved by TUF in 70.0 percent of 240 patients; 18 patients underwent cystectomy for intractable pain. (HealthDay News) — For patients with interstitial cystitis (IC ...

SGLT2 inhibitors may enable continuation of RAAS inhibitors for hypertension treatment, which is linked with better kidney and cardiovascular outcomes.

Patients with diabetic macular edema treated with intravitreal aflibercept have a significantly higher risk of adverse renal events compared with those treated with ranibizumab.

The prophylactic efficacy of TMP-SMX was significantly higher in subgroups with baseline lymphopenia, azotemia, microscopic polyangiitis, or relapsed AAV.

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1 ...

Iron therapy may reduce the risk of heart failure hospitalization and cardiovascular death in patients with CKD, according to a meta-analysis of randomized trials. Iron therapy for chronic kidney ...

Geographic disparities seen, with greater percentage of cardiovascular deaths attributable to di-2-ethylhexylphthalate exposure for South Asia, Middle East.